OPELLA HEALTHCARE INTERNATIONAL SAS : revenue, balance sheet and financial ratios

OPELLA HEALTHCARE INTERNATIONAL SAS is a French company founded 7 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in NEUILLY-SUR-SEINE (92200), this company of category GE shows in 2024 a revenue of 2.0 Mds€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - OPELLA HEALTHCARE INTERNATIONAL SAS (SIREN 844718551)
Indicator 2024 2023 2020 2019
Revenue 1 954 000 000 € 2 101 000 000 € N/C N/C
Net income 46 000 000 € 52 000 000 € -375 € -9 844 €
EBITDA 1 146 000 000 € 1 384 000 000 € -375 € -9 844 €
Net margin 2.4% 2.5% N/C N/C

Revenue and income statement

In 2024, OPELLA HEALTHCARE INTERNATIONAL SAS achieves revenue of 2.0 Bn€. Revenue is declining over the period 2023-2024 (CAGR: -7.0%). Slight decline of -7% vs 2023. After deducting consumption (355.0 M€), gross margin stands at 1.6 Bn€, i.e. a rate of 82%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.1 Bn€, representing 58.6% of revenue. Warning negative scissor effect: despite revenue change (-7%), EBITDA varies by -17%, reducing margin by 7.2 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 46.0 M€, i.e. 2.4% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

1 954 000 000 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 599 000 000 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

1 146 000 000 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

64 000 000 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

46 000 000 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

58.6%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 5.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1.871%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

50.085%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

5.067%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.111

Solvency indicators evolution
OPELLA HEALTHCARE INTERNATIONAL SAS

Sector positioning

Debt ratio
1.87 2024
2020
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Good +20 pts over 3 years

In 2024, the debt ratio of OPELLA HEALTHCARE INTERNA... (1.87) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
50.09% 2024
2020
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Good +38 pts over 3 years

In 2024, the financial autonomy of OPELLA HEALTHCARE INTERNA... (50.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.11 years 2024
2020
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.09 years
Average +28 pts over 3 years

In 2024, the repayment capacity of OPELLA HEALTHCARE INTERNA... (0.11) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 93 days. Excellent situation: suppliers finance 93 days of the operating cycle (retail model). WCR is negative (-36 days): operations structurally generate cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

-192 996 580 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

93 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

-36 j

WCR and payment terms evolution
OPELLA HEALTHCARE INTERNATIONAL SAS

Positioning of OPELLA HEALTHCARE INTERNATIONAL SAS in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of OPELLA HEALTHCARE INTERNATIONAL SAS is estimated at 535 729 720 € (range 261 244 074€ - 1 873 720 165€). With an EBITDA of 1 146 000 000€, the sector multiple of 0.7x is applied. The price/revenue ratio is 0.21x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
124 transactions
261244k€ 535729k€ 1873720k€
535 729 720 € Range: 261 244 074€ - 1 873 720 165€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
1 146 000 000 € × 0.7x
Estimation 806 652 366 €
381 333 319€ - 2 935 920 312€
Revenue Multiple 30%
1 954 000 000 € × 0.21x
Estimation 416 151 979 €
225 669 356€ - 1 260 531 188€
Net Income Multiple 20%
46 000 000 € × 0.8x
Estimation 37 789 720 €
14 383 039€ - 138 003 266€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare OPELLA HEALTHCARE INTERNATIONAL SAS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about OPELLA HEALTHCARE INTERNATIONAL SAS

What is the revenue of OPELLA HEALTHCARE INTERNATIONAL SAS ?

The revenue of OPELLA HEALTHCARE INTERNATIONAL SAS in 2024 is 2.0 Mds€.

Is OPELLA HEALTHCARE INTERNATIONAL SAS profitable?

Yes, OPELLA HEALTHCARE INTERNATIONAL SAS generated a net profit of 46.0 M€ in 2024.

Where is the headquarters of OPELLA HEALTHCARE INTERNATIONAL SAS ?

The headquarters of OPELLA HEALTHCARE INTERNATIONAL SAS is located in NEUILLY-SUR-SEINE (92200), in the department Hauts-de-Seine.

Where to find the tax return of OPELLA HEALTHCARE INTERNATIONAL SAS ?

The tax return of OPELLA HEALTHCARE INTERNATIONAL SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does OPELLA HEALTHCARE INTERNATIONAL SAS operate?

OPELLA HEALTHCARE INTERNATIONAL SAS operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.